Pharmacy benefit managers (PBMs) are coming under increased public scrutiny for their role in the healthcare industry. Last month the FTC released an interim report on their two-year investigation into PBMs vertical integration and drug pricing. Which is seemingly in preparation to sue the three largest PBMs for their tactics to negotiate drug prices between manufacturers and clients.
Read Full Article »
